SEARCH

SEARCH BY CITATION

References

  • 1
    Proceedings of the National Institutes of Health State-of-the-Science Conference, Diagnosis and Management of Ductal Carcinoma In Situ. September 2009. J Natl Cancer Inst Monogr. 2010; 2010( 41): 111-222.
  • 2
    Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst. 2010; 102: 161-169.
  • 3
    McCaskill-Stevens W. National Institutes of Health State-of-the-Science Conference on the Management and Diagnosis of Ductal Carcinoma in Situ: a call to action. J Natl Cancer Inst Monogr. 2010; 2010( 41): 111-112.
  • 4
    Graff S. Ductal carcinoma in situ: should the name be changed? J Natl Cancer Inst. 2010; 102: 6-8.
  • 5
    StatBite: relative survival and incidence rates: ductal carcinoma in situ. J Natl Cancer Inst. 2010; 102: 8.
  • 6
    Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010; 2010( 41): 139-141.
  • 7
    DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011; 61: 409-418.
  • 8
    Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004; 96: 906-920.
  • 9
    Allred DC. Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone. J Natl Cancer Inst. 2010; 102: 585-587.
  • 10
    Bijker N, van Tienhoven G. Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective. J Natl Cancer Inst Monogr. 2010; 2010( 41): 178-180.
  • 11
    Schnitt SJ. Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics. J Natl Cancer Inst Monogr. 2010; 2010( 41): 158-161.
  • 12
    Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005; 103: 2481-2484.
  • 13
    Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004; 350: 1430-1441.
  • 14
    Solin LJ, Gray R, Baehner FL, et al. A quantitative multigene RT-PCR assay for predicting recurrence risk after surgical excision alone without irradiation for ductal carcinoma in situ (DCIS): a prospective validation study of the DCIS score from ECOG E5194. Cancer Res. 2011; 71( suppl 24): 108s.
  • 15
    Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van de Vijver MJ, eds. WHO Classification of Tumours of the Breast. Lyon: IARC Press. In press.
  • 16
    Kerlikowske K, Molinaro AM, Gauthier ML, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010; 102: 627-637.
  • 17
    Fong J, Kurniawan ED, Rose AK, et al. Outcomes of screening-detected ductal carcinoma in situ treated with wide excision alone. Ann Surg Oncol. 2011; 18: 3778-3784.
  • 18
    Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000; 320: 1635-1640.
  • 19
    Webb C, Koch T. Women's experiences of non-invasive breast cancer: literature review and study report. J Adv Nurs. 1997; 25: 514-525.
  • 20
    Godby CJ. Women's attitudes to false positive mammography results. A formerly clueless patient responds. BMJ. 2000; 321: 1409-1410; discussion 1410-1411.
  • 21
    De Morgan S, Redman S, White KJ, Cakir B, Boyages J. “Well, have I got cancer or haven't I?” The psycho-social issues for women diagnosed with ductal carcinoma in situ. Health Expect. 2002; 5: 310-318.
  • 22
    Prinjha S, Evans J, McPherson A. Women's information needs about ductal carcinoma in situ before mammographic screening and after diagnosis: a qualitative study. J Med Screen. 2006; 13: 110-114.
  • 23
    De Morgan S, Redman S, D'Este C, Rogers K. Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns. 2011; 84: 62-68.
  • 24
    Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B. Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions. Eur J Cancer Care (Engl). 2011; 20: 776-784.
  • 25
    Carrera C, Payne S. Ductal carcinoma in situ (DCIS) of the breast: the need for psychosocial research. Psychooncology. 1999; 8: 538-545.
  • 26
    Kennedy F, Harcourt D, Rumsey N. The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS). Eur J Oncol Nurs. 2008; 12: 103-111.
  • 27
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. New York: Springer; 2010: 646.
  • 28
    Partridge A, Winer JP, Golshan M, et al. Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008; 8: 275-280.
  • 29
    Katz SJ, Lantz PM, Zemencuk JK. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. J Womens Health Gend Based Med. 2001; 10: 659-670.
  • 30
    Ceilley E, Jagsi R, Goldberg S, Kachnic L, Powell S, Taghian A. The management of ductal carcinoma in situ in North America and Europe. Results of a survey. Cancer. 2004; 101: 1958-1967.
  • 31
    Ceilley E, Jagsi R, Goldberg S, et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys. 2005; 61: 365-373.
  • 32
    Katz SJ, Lantz PM, Janz NK, et al. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005; 23: 3001-3007.
  • 33
    Yen TW, Kuerer HM, Ottesen RA, et al. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol. 2007; 25: 3251-3258.
  • 34
    Kennedy F, Harcourt D, Rumsey N. Perceptions of ductal carcinoma in situ (DCIS) among UK health professionals. Breast. 2009; 18: 89-93.
  • 35
    Cutuli B, Lemanski C, Fourquet A, et al. Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. Br J Cancer. 2009; 100: 1048-1054.
  • 36
    Kaplan CP, Napoles AM, Hwang ES, et al. Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health (Larchmt). 2011; 20: 215-223.
  • 37
    Amichetti M, Caffo O, Arcicasa M, et al. Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation. Breast Cancer Res Treat. 1999; 54: 109-115.
  • 38
    Nekhlyudov L, Kroenke CH, Jung I, Holmes MD, Colditz GA. Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study. J Clin Oncol. 2006; 24: 2822-2827.
  • 39
    Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008; 100: 243-251.
  • 40
    Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP. Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med. 2001; 10: 589-598.
  • 41
    Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003; 77: 285-293.
  • 42
    van Gestel YR, Voogd AC, Vingerhoets AJ, et al. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer. 2007; 43: 549-556.
  • 43
    Liu Y, Perez M, Aft RL, et al. Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev. 2010; 19: 675-680.
  • 44
    Liu Y, Perez M, Schootman M, et al. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat. 2010; 124: 835-844.
  • 45
    Kennedy F, Harcourt D, Rumsey N, White P. The psychosocial impact of ductal carcinoma in situ (DCIS): a longitudinal prospective study. Breast. 2010; 19: 382-387.
  • 46
    Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2011; 130: 165-173.
  • 47
    Ruddy K, Meyer M, Giobbie-Hurder A, et al. Long-Term Risk Perceptions and Quality of Life of Women with Ductal Carcinoma In Situ. Cancer Res. 2010. Abstract P2-15-01.
  • 48
    Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997; 44: 681-692.
  • 49
    Mulley AG Jr. Assessing patients' utilities. Can the ends justify the means? Med Care. 1989; 27( suppl 3): S269-S281.
  • 50
    Epstein RM, Street RL. Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. Bethesda, MD: National Cancer Institute; 2007.
  • 51
    Elmore JG, Ganschow PS, Geller BM. Communication between patients and providers and informed decision making. J Natl Cancer Inst Monogr. 2010; 2010( 41): 204-209.
  • 52
    Fowler FJ Jr, Levin CA, Sepucha KR. Informing and involving patients to improve the quality of medical decisions. Health Aff (Millwood). 2011; 30: 699-706.
  • 53
    Arora NK, Street RL Jr, Epstein RM, Butow PN. Facilitating patient-centered cancer communication: a road map. Patient Educ Couns. 2009; 77: 319-321.
  • 54
    Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL. Physicians' decision-making style and psychosocial outcomes among cancer survivors. Patient Educ Couns. 2009; 77: 404-412.
  • 55
    Napoles-Springer AM, Livaudais JC, Bloom J, Hwang S, Kaplan CP. Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ. J Psychosoc Oncol. 2007; 25: 19-36.
  • 56
    O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009( 3): CD001431.
  • 57
    Whelan T, Levine M, Willan A, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. 2004; 292: 435-441.
  • 58
    Collins ED, Moore CP, Clay KF, et al. Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol. 2009; 27: 519-525.
  • 59
    Tavassoli FA. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol. 1998; 11: 140-154.
  • 60
    Tavassoli FA. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification. Nat Clin Pract Oncol. 2005; 2: 116-117.
  • 61
    Veronesi U, Viale G, Rotmensz N, Goldhirsch A. Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. Breast. 2006; 15: 3-8.
  • 62
    Veronesi U, Zurrida S, Goldhirsch A, Rotmensz N, Viale G. Breast cancer classification: time for a change. J Clin Oncol. 2009; 27: 2427-2428.
  • 63
    Veronesi U, Zurrida S, Viale G, Galimberti V, Arnone P, Nole F. Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J. 2009; 15: 291-295.